Cargando…

Proton Pump Inhibitors Increase the Risk of Autoimmune Diseases: A Nationwide Cohort Study

BACKGROUND: Previous study revealed proton pump inhibitors (PPIs) have an effect on gut microbiota. Alteration of the microbiome causes changes of the host immune system and then induces the development of autoimmune diseases (ADs). This study aimed to explore the possible association between PPIs u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Sheng-Hong, Chang, Yu-Sheng, Lin, Tzu-Min, Hu, Li-Fang, Hou, Tsung-Yun, Hsu, Hui-Ching, Shen, Yu-Chuan, Kuo, Pei-I, Chen, Wei-Sheng, Lin, Yi-Chun, Chen, Jin-Hua, Chang, Chi-Ching
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514990/ https://www.ncbi.nlm.nih.gov/pubmed/34659225 http://dx.doi.org/10.3389/fimmu.2021.736036

Ejemplares similares

Pneumocystis jirovecii pneumonia in autoimmune rheumatic diseases: a nationwide population-based study
por: Hsu, Hui-Ching, et al.
Publicado: (2021)

Association of interferon-based therapy with risk of autoimmune diseases in patients with chronic hepatitis C virus infection: A population-based Taiwanese cohort study
por: Chou, Shu-Ming, et al.
Publicado: (2022)

Risk of incident autoimmune diseases in patients with thymectomy
por: Lin, Tzu‐Min, et al.
Publicado: (2020)

Higher risk of dementia in primary Sjogren's syndrome
por: Hou, Tsung‐Yun, et al.
Publicado: (2019)

Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan
por: Tai, Shu-Yu, et al.
Publicado: (2017)

CYP2C19 genotypes and osteoporotic fractures in long‐term users of proton pump inhibitors: A hospital‐based study
por: Liao, Yi‐Ju, et al.
Publicado: (2023)

Autoimmune rheumatic diseases increase dementia risk in middle-aged patients: A nationwide cohort study
por: Lin, Tzu-Min, et al.
Publicado: (2018)

Primary Sjogren syndrome increases the risk of bisphosphonate-related osteonecrosis of the jaw
por: Kuo, Pei-I, et al.
Publicado: (2021)

The Impact of Proton Pump Inhibitors on the Development of Gastric Neoplastic Lesions in Patients With Autoimmune Atrophic Gastritis
por: Dilaghi, Emanuele, et al.
Publicado: (2022)

Increased risk of early-onset childhood systemic lupus erythematosus for children born to affected parents: A nationwide child-parent cohort study
por: Wu, Chun-Hsin, et al.
Publicado: (2022)

Investigation of the interaction between proton pump inhibitors and clopidogrel using VerifyNow P2Y12 assay
por: Lin, Sheng-Feng, et al.
Publicado: (2020)

H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection
por: Shen, Yu-Chuan, et al.
Publicado: (2022)

Proton Pump Inhibitors Did Not Increase Risk of Pneumonia in Patients With Chronic Obstructive Pulmonary Disease
por: Lee, Shou-Wu, et al.
Publicado: (2015)

Concurrent proton-pump inhibitors increase risk of death for lung cancer patients receiving 1st-line gefitinib treatment - a nationwide population-based study
por: Fang, Yu-Hung, et al.
Publicado: (2019)

Innate Immune Responses of Vaccinees Determine Early Neutralizing Antibody Production After ChAdOx1nCoV-19 Vaccination
por: Shen, Ching-Fen, et al.
Publicado: (2022)

A Real World Report on Intravenous High-Dose and Non-High-Dose Proton-Pump Inhibitors Therapy in Patients with Endoscopically Treated High-Risk Peptic Ulcer Bleeding
por: Lu, Lung-Sheng, et al.
Publicado: (2012)

Dose-Dependent Proton Pump Inhibitor Exposure and Risk of Type 2 Diabetes: A Nationwide Nested Case–Control Study
por: Kuo, Hsin-Ya, et al.
Publicado: (2022)

Effect of proton pump inhibitors on sympathetic hyperinnervation in infarcted rats: Role of magnesium
por: Lee, Tsung-Ming, et al.
Publicado: (2018)

Therapeutic Role of Inducible Nitric Oxide Synthase Expressing Myeloid-Derived Suppressor Cells in Acetaminophen-Induced Murine Liver Failure
por: Hsu, Chen-Yu, et al.
Publicado: (2020)

Proton pump inhibitor use and the risk for Parkinson’s disease: A nationwide population-based study in Taiwan
por: Chen, Huan-Lin, et al.
Publicado: (2023)

The Association between Baseline Proton Pump Inhibitors, Immune Checkpoint Inhibitors, and Chemotherapy: A Systematic Review with Network Meta-Analysis
por: Chang, Yu, et al.
Publicado: (2022)

Primary Sjogren’s syndrome and the risk of acute pancreatitis: a nationwide cohort study
por: Chang, Chi-Ching, et al.
Publicado: (2017)

Effects of annual influenza vaccination on morbidity and mortality in patients with Systemic Lupus Erythematosus: A Nationwide Cohort Study
por: Chang, Chi-Ching, et al.
Publicado: (2016)

TRAIL-Mediated Suppression of T Cell Receptor Signaling Inhibits T Cell Activation and Inflammation in Experimental Autoimmune Encephalomyelitis
por: Chyuan, I-Tsu, et al.
Publicado: (2018)

Long-Term Usage of Proton Pump Inhibitors Associated with Prognosis in Patients with Colorectal Cancer
por: Wu, Chin-Chia, et al.
Publicado: (2023)

Uveitis increases the risk of stroke among patients with ankylosing spondylitis: A nationwide population-based longitudinal study
por: Tsung, Ta-hsin, et al.
Publicado: (2022)

Proton Pump Inhibitor-unresponsive Laryngeal Symptoms Are Associated With Psychological Comorbidities and Sleep Disturbance: A Manometry and Impedance-pH Monitoring Study
por: Tseng, Wen-Hsuan, et al.
Publicado: (2023)

Impact of Antibiotics and Proton Pump Inhibitors on Efficacy and Tolerance of Anti-PD-1 Immune Checkpoint Inhibitors
por: Giordan, Quentin, et al.
Publicado: (2021)

Electroconvulsive Therapy and Risk of Dementia—A Nationwide Cohort Study in Taiwan
por: Chu, Ching-Wen, et al.
Publicado: (2018)

The Application of High-Dose Proton Pump Inhibitor Induction Treatment before Dual Therapy for Helicobacter pylori Eradication: An Open-Label Random Trial
por: Chen, Li-Wei, et al.
Publicado: (2021)

The Association between Proton Pump Inhibitors and the Effectiveness of CDK Inhibitors in HR+/HER- Advanced Breast Cancer Patients: A Systematic Review and Meta-Analysis
por: Chang, Yu-Cheng, et al.
Publicado: (2023)

Proton pump inhibitors use is associated with a lower risk of acute exacerbation and mortality in patients with coexistent COPD and GERD
por: Su, Vincent Yi-Fong, et al.
Publicado: (2018)

Do proton pump inhibitors alter the response to immune checkpoint inhibitors in cancer patients? A meta-analysis
por: Lopes, Sébastien, et al.
Publicado: (2023)

Proton pump inhibitor use and risk of hip fracture in patients with type 2 diabetes
por: Chou, Ya-Shuan, et al.
Publicado: (2020)

Proteasome Inhibitor Bortezomib Suppresses Nuclear Factor-Kappa B Activation and Ameliorates Eye Inflammation in Experimental Autoimmune Uveitis
por: Hsu, Sheng-Min, et al.
Publicado: (2015)

Bladder volume reproducibility after water consumption in patients with prostate cancer undergoing radiotherapy: A systematic review and meta-analysis
por: Chen, Hsiao-Hsuan, et al.
Publicado: (2021)

A Novel CD3G Mutation in a Taiwanese Patient With Normal T Regulatory Function Presenting With the CVID Phenotype Free of Autoimmunity—Analysis of all Genotypes and Phenotypes
por: Lee, Wen-I, et al.
Publicado: (2019)

Exposure to proton pump inhibitors is associated with the development of pediatric autoimmune diseases
por: Räisänen, Laura, et al.
Publicado: (2023)

Epidemiology and risk of invasive fungal infections in systemic lupus erythematosus: a nationwide population-based cohort study
por: Su, Chin-Fang, et al.
Publicado: (2021)

Fluoroquinolones versus β-Lactam/β-Lactamase Inhibitors in Outpatients with Chronic Obstructive Pulmonary Disease and Pneumonia: A Nationwide Population-Based Study
por: Lin, Kuan-Yin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2li5bo8at00kchd5mjgt0rub4r